Our data point to the idea that the YAP-TEAD-COX-2/PGE2 signaling pathway is an important regulator of the Taxol response in CRC cells, as well as that dual YAP and COX-2 inhibition is a novel therapeutic approach to treat drug-resistant colorectal cancers. The gene discussed is PTGS2; the disease is colorectal carcinoma.